A Delaware court has upheld two patents in favor of Pronova's heart drug Lovaza, ruling against...

|By:, SA News Editor

A Delaware court has upheld two patents in favor of Pronova's heart drug Lovaza, ruling against Par Pharmaceutical (PRX) and Teva Pharmaceutical (TEVA). The ruling prevents Par and Teva from selling generic versions of Lovaza, which lowers very high levels of triglycerides in the bloodstream.